-- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
Securities code: 600535 Securities abbreviation: Tasly Number: Lin 2025-067 Tasly Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the Fifth Extraordinary General Meeting of Shareholders in 2025
The board of directors and all directors of the company guarantee that the contents of this announcement do not contain any false records or misleading statements.
or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: October 10, 2025
(2) The location of the general meeting of shareholders: Tasly Pharmaceutical Group Co., Ltd. conference room
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 1,457
Total number of shares with voting rights held by shareholders attending the meeting (shares) 659,271,256
Proportion of the number of voting shares held by shareholders attending the meeting to the total number of voting shares of the company (%) 46.4520
(4) Whether the voting method complies with the provisions of the "Company Law" and "Articles of Association", the status of the meeting, etc.
This meeting will be held and voted through a combination of on-site voting and online voting. The meeting was convened by the company's board of directors. According to the relevant provisions of the "Articles of Association", the chairman of the board, Ms. Zhou Hui, presided over the meeting on the spot. The convening and holding of the meeting complied with the provisions of relevant laws, regulations, rules and the Articles of Association.
(5) Attendance of the company’s directors, supervisors and board secretary
The company has 15 current directors and 15 people are present;
The company has 5 current supervisors and 5 persons present;
Mr. Yu Jie, secretary of the board of directors, attended the shareholders' meeting; Ms. Wei Jie, the financial director, attended the meeting.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal title: Proposal on using idle funds to purchase bank financial products
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Number of votes Proportion (%) Number of votes Proportion (%) Number of votes Proportion (%)
A shares 626,053,129 94.9613 32,850,267 4.9828 367,860 0.0559
(2) Regarding major matters, the voting situation of shareholders below 5%
Agree Objection Abstain motion
Motion name Proportion Proportion number Number of votes Number of votes Number of votes
(%) (%) (%) Regarding the use of idle resources
1 gold purchase bank financial management 25,280,094 43.2151 32,850,267 56.1560 367,860 0.6289
product proposals
(3) Explanation of relevant circumstances regarding voting on motions
The resolutions at this meeting are non-cumulative voting resolutions;
The resolutions at this meeting are non-special resolutions and shall be passed by more than half of the valid votes held by shareholders or shareholder representatives present at the meeting;
The resolutions of this meeting were separately counted for the votes of less than 5% of shareholders.
3. Lawyer’s testimony
- The law firm witnessing this general meeting of shareholders: Inner Mongolia Jianzhong Law Firm
Lawyers: Guo Ruipeng, Zhang Xinyu
- Lawyer’s concluding comments:
This shareholders' meeting was legally witnessed by lawyers Guo Ruipeng and Zhang Xinyu of Inner Mongolia Jianzhong Law Firm, and the "Legal Opinion" issued by the company held that: the company's convening and convening procedures of this shareholders' meeting complied with the provisions of relevant laws, regulations, normative documents and the "Articles of Association", the qualifications of the personnel attending this shareholders' meeting are legal and valid, and the voting procedures and voting results of this shareholders' meeting are legal and valid.
Announcement is hereby made.
Tasly Pharmaceutical Group Co., Ltd. Board of Directors
October 11, 2025
Online announcement documents
A legal opinion signed and stamped by the director of the law firm witnessed by
Reporting documents
Resolutions of the general meeting of shareholders signed and confirmed by the directors present and the recorder and stamped with the seal of the board of directors